Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
C514S255030, C544S238000, C544S360000, C544S359000, C544S400000
One aspect of the present invention relates to novel heterocyclic compounds. A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various cellular receptors, including serotonin receptors and dopamine receptors. The compounds of the present invention will find use in the treatment of numerous ailments, conditions and diseases which afflict mammals, including but not limited to addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, Alzheimer's disease, obesity, emesis, psychosis, analgesia, schizophrenia, Parkinson's disease, restless leg syndrome, sleeping disorders, attention deficit hyperactivity disorder, irritable bowel syndrome, premature ejaculation, menstrual dysphoria syndrome, urinary incontinence, inflammatory pain, neuropathic pain, Lesche-Nyhane disease, Wilson's disease, Tourette's syndrome, psychiatric disorders, stroke, and senile dementia.
patent: 2833770 (1958-05-01), Parcell et al.
patent: 6071920 (2000-06-01), Leonardi et al.
patent: 0 048 045 (1982-03-01), None
Anneke Hackling et al., N-(omega-(4-(2-Methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as Dpoamine D2 and D3 Receptor Ligands, J. Med. Chem. 46, pp. 3883-3899, 2003.
Hauske James R.
Holland Joanne M.
Radeke Heike S.
Foley & Hoag LLP
Gordon Dana M.
1,4-disubstituted piperazine ligands for neurotransmitter... does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with 1,4-disubstituted piperazine ligands for neurotransmitter..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,4-disubstituted piperazine ligands for neurotransmitter... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3589474